NCT02057900View on ClinicalTrials.gov

Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 27, 2013

Primary Completion Date

March 22, 2018

Study Completion Date

March 22, 2018

Conditions
Ischemic Heart Disease
Interventions
BIOLOGICAL

Human embryonic stem cell-derived CD15+ Isl-1+ progenitors

Epicardial delivery of a fibrin patch embedding human embryonic stem cell-derived CD15+ Isl-1+ progenitors

Trial Locations (1)

75015

Department of Cardiovascular Surgery, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02057900 - Transplantation of Human Embryonic Stem Cell-derived Progenitors in Severe Heart Failure | Biotech Hunter | Biotech Hunter